SEC Form 4 · accession 0001053369-15-000012
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nasrat A Hakim
Officer — President & CEO · Director · 10% Owner
Period of report
Apr 3, 2015
Accepted (ET)
Apr 8, 2015 · 11:21 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants | $0.0625 | Apr 3, 2015 | J | 1,982,106 | A | Mar 31, 2011 | Mar 31, 2018 | Common Stock | 1,982,106 | 1,982,106 | I |
Explanation of responses
- F1Disposition of warrants to members of Epic Pharma, LLC